TGFB1 and cardiovascular disorder: Moreover, it has been found that, through inhibition of TGF-β, these adverse effects can be limited; thus, TGF-β inhibitors combined with chemotherapy may be a tangible approach to increase patient prognosis and reduce cardiovascular disease.